Stay updated on Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.

Latest updates to the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check48 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check63 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check70 days agoChange DetectedThe website has updated the intervention details to include a verified status by Revolution Medicines, Inc. and has revised the version to v2.14.0, while removing the previous type of intervention from version v2.13.3.SummaryDifference3%
- Check99 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.